Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Mucopolysaccharidosis VI
- Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI
- A Study in MPS VI to Assess Safety and Efficacy of Odiparcil
- Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
- MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
- Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
- Human Placental-Derived Stem Cell Transplantation
- Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
- Clinical Trial of Growth Hormone in MPS I, II, and VI
- Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
- A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
- Stem Cell Transplantation for Hurler
- Study of rhASB in Patients With Mucopolysaccharidosis VI
- Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI
- Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI
- Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI